학술논문
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
Document Type
Article
Author
Source
In The Lancet Respiratory Medicine April 2022 10(4):392-402
Subject
Language
ISSN
2213-2600